HHUAHomo sapiens (Human)Cancer cell line

Also known as: HHUA-1

🤖 AI SummaryBased on 5 publications

Quick Overview

HHUA is a human endometrial adenocarcinoma cell line established from a well-differentiated tumor.

Detailed Summary

HHUA is a human endometrial adenocarcinoma cell line established from a well-differentiated tumor. It exhibits characteristics of epithelial cells, forming multilayers without contact inhibition. The cell line shows a stable proliferation over long periods and has been subcultivated multiple times. HHUA cells contain both estradiol-17β and progesterone receptors, and their receptor levels can be modulated by hormone administration. Additionally, HHUA has been used in studies related to tumor angiogenesis and genetic alterations, including Rb gene changes and p53 mutations. The cell line is transplantable in nude mice, forming tumors that resemble adenocarcinomas. These properties make HHUA a valuable tool for studying endometrial cancer biology and therapeutic responses.

Research Applications

Tumor angiogenesisGenetic alterations (Rb, p53)Hormone receptor studiesIn vivo transplantation (nude mice)

Key Characteristics

Epithelial morphologyNo contact inhibitionStable long-term proliferationEstradiol-17β and progesterone receptorsTransplantable in nude mice
Generated on 6/20/2025

Basic Information

Database IDCVCL_3866
SpeciesHomo sapiens (Human)
Tissue SourceEndometrium[UBERON:UBERON_0001295]

Donor Information

Age54
Age CategoryAdult
SexFemale

Disease Information

DiseaseEndometrial adenocarcinoma
LineageUterus
SubtypeEndometrial Carcinoma
OncoTree CodeUCEC

DepMap Information

Source TypeRIKEN
Source IDACH-002026_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Ala138Val (c.413C>T)Unspecified-PubMed=8105795

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11,12
D13S317
8,11
D16S539
10,12
D18S51
12,18,19
D21S11
29,30
D3S1358
14,15
D5S818
9,12,13,14
D7S820
10,13
D8S1179
11,13
FGA
21,22
Penta D
8,11
Penta E
11,13
TH01
6,7
TPOX
8,9
vWA
17,18,19
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Correlation between DNA alterations and p53 and p16 protein expression in cancer cell lines.

Murai Y., Hayashi S., Takahashi H., Tsuneyama K., Takano Y.

Pathol. Res. Pract. 201:109-115(2005).

Tumor angiogenesis factors produced by cancer cells.";

Ishiwata I., Sudo T., Kiguchi K., Ishikawa H.

Hum. Cell 12:37-46(1999).

Effects of feeder cells (human cancer cell lines) on the development of mouse embryos by co-culture.

Ishikawa H.

Hum. Cell 10:237-246(1997).

Tissue reconstruction of gynecologic tumor cells in the rotation culture system.

Hashimoto H., Tachibana T., Ishikawa H., Nozawa S.

Hum. Cell 10:175-181(1997).

Alterations of the Rb gene and its association with Ki-ras activation and p53 inactivation in endometrial adenocarcinoma.

Nomura T.

Mol. Carcinog. 8:132-137(1993).

Establishment of human endometrial adenocarcinoma cell line containing estradiol-17 beta and progesterone receptors.

Ishiwata I., Ishiwata C., Soma M., Arai J., Ishikawa H.

Gynecol. Oncol. 17:281-290(1984).

Effects of estradiol-17 beta and progesterone on cell proliferation and differentiation of the human endometrial carcinoma cell line (HHUA) in vitro.

Ishiwata I., Ishiwata C., Ishikawa H.

Asia Oceania J. Obstet. Gynaecol. 10:531-538(1984).

Tumor angiogenic activity of gynecologic tumor cell lines on the chorioallantoic membrane.

Ishiwata I., Ishiwata C., Soma M., Ono I., Nakaguchi T., Ishikawa H.

Gynecol. Oncol. 29:87-93(1988).

CA125 production by gynecologic tumors in vitro and its modulation induced by dibutyl cyclic adenosine monophosphate.

Ishiwata I., Ishiwata C., Nozawa S., Ishikawa H.

Asia Oceania J. Obstet. Gynaecol. 12:285-290(1986).